Microbiotica is a clinical-stage biopharmaceutical company that translates microbiome science into medicines, developing defined live biotherapeutic products.
Microbiotica has raised €61M across 1 funding round from 6 investors, most recently a Series B round in Mar 2022. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-07 | Series B | €61M |
| British Patient Capital,Cambridge Innovation Capital,Flerie Invest,IP Group,Seventure Partners,Tencent |
| View deal → |
